The expression profile of integrin receptors and osteopontin in thyroid malignancies varies depending on the tumor progression rate and presence of BRAF V600E mutation

BRAF V600E mutation, Integrins, Osteopontin, Thyroid cancer, NODULES, CANCER, NEEDLE-ASPIRATION-CYTOLOGY, Prognosis, Follow-Up Studies, Humans, Osteopontin/genetics, Proto-Oncogene Proteins B-raf/genetics, Case-Control Studies, Thyroid Neoplasms/genetics, Biomarkers, Tumor/genetics, Integrins/genetics, Neoplasm Metastasis, Mutation, Carcinoma, Papillary/genetics

ID: 17118611